New drug combo aims to control advanced cancers
Disease control
Not yet recruiting
This study tests an experimental drug called LRK-4189, given alone or with standard chemotherapy, in adults with advanced solid tumors (like colorectal cancer) that have not responded to prior treatment. The main goals are to check safety and find the best dose. Participants take…
Phase: PHASE1, PHASE2 • Sponsor: LARKSPUR BIOSCIENCES, INC. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC